Published in J Virol on September 05, 2007
The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev (2009) 2.02
Pseudodiploid genome organization AIDS full-length human immunodeficiency virus type 1 DNA synthesis. J Virol (2007) 0.89
The Host RNAs in Retroviral Particles. Viruses (2016) 0.76
Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication. J Mol Biol (2016) 0.75
Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J Gen Virol (1979) 7.69
A minimal intron length but no specific internal sequence is required for splicing the large rabbit beta-globin intron. Cell (1984) 5.37
Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. Proc Natl Acad Sci U S A (1993) 4.04
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci U S A (2005) 3.94
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc Natl Acad Sci U S A (1990) 3.76
Retroviral RNA packaging: sequence requirements and implications. Curr Top Microbiol Immunol (1990) 3.22
High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol (2000) 3.09
Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication. Science (1993) 2.64
Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J Virol (2002) 2.50
Assays for retroviral reverse transcriptase. Methods Enzymol (1995) 2.43
Retroviral DNA H structures: displacement-assimilation model of recombination. Cell (1982) 2.37
Mechanism of transduction by retroviruses. Science (1992) 2.37
Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer. J Virol (1991) 2.34
High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication. J Virol (2003) 2.04
Transfer RNA into RNA tumor viruses. Prog Nucleic Acid Res Mol Biol (1977) 1.99
Mechanisms of retroviral mutation. Trends Microbiol (1996) 1.85
Selective and nonselective packaging of cellular RNAs in retrovirus particles. J Virol (2007) 1.79
Requirements for different components of the host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis from entry via surface fusion. J Virol (1997) 1.75
Comparison of Moloney murine leukemia virus mutation rate with the fidelity of its reverse transcriptase in vitro. J Biol Chem (1992) 1.73
Retrovirus recombination depends on the length of sequence identity and is not error prone. J Virol (1994) 1.70
Efficient packaging of readthrough RNA in ALV: implications for oncogene transduction. Science (1987) 1.65
Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications. J Virol (1995) 1.62
Generation of retroviral vector for clinical studies using transient transfection. Hum Gene Ther (1999) 1.57
The nature of human immunodeficiency virus type 1 strand transfers. J Biol Chem (1998) 1.52
Human immunodeficiency virus type 1 genetic recombination is more frequent than that of Moloney murine leukemia virus despite similar template switching rates. J Virol (2003) 1.52
Site-specific footprinting reveals differences in the translocation status of HIV-1 reverse transcriptase. Implications for polymerase translocation and drug resistance. J Biol Chem (2003) 1.52
Determinants of the RNase H cleavage specificity of human immunodeficiency virus reverse transcriptase. Nucleic Acids Res (1993) 1.46
Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infection. J Virol (2003) 1.44
Altering the intracellular environment increases the frequency of tandem repeat deletion during Moloney murine leukemia virus reverse transcription. J Virol (1999) 1.42
When retroviral reverse transcriptases reach the end of their RNA templates. J Virol (1992) 1.36
3' junctions of oncogene-virus sequences and the mechanisms for formation of highly oncogenic retroviruses. J Virol (1993) 1.36
A model system for nonhomologous recombination between retroviral and cellular RNA. J Virol (1993) 1.32
Rearrangements in unintegrated retroviral DNA are complex and are the result of multiple genetic determinants. J Virol (1990) 1.31
Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc Natl Acad Sci U S A (1996) 1.30
Nonrandom packaging of host RNAs in moloney murine leukemia virus. J Virol (2005) 1.30
High-frequency recombination within the gag gene of Rous sarcoma virus. J Virol (1979) 1.30
Most retroviral recombinations occur during minus-strand DNA synthesis. J Virol (2000) 1.24
Effects of varying sequence similarity on the frequency of repeat deletion during reverse transcription of a human immunodeficiency virus type 1 vector. J Virol (2002) 1.16
Replication of lengthened Moloney murine leukemia virus genomes is impaired at multiple stages. J Virol (2000) 1.13
Nonrandom dimerization of murine leukemia virus genomic RNAs. J Virol (2004) 1.11
Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses. J Virol (2000) 1.09
Evidence for a mechanism of recombination during reverse transcription dependent on the structure of the acceptor RNA. J Biol Chem (2003) 1.08
High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy. J Virol (2006) 1.08
Evidence for preferential copackaging of Moloney murine leukemia virus genomic RNAs transcribed in the same chromosomal site. Retrovirology (2005) 1.06
Effects of limiting homology at the site of intermolecular recombinogenic template switching during Moloney murine leukemia virus replication. J Virol (2001) 1.06
Strand transfer occurs in retroviruses by a pause-initiated two-step mechanism. J Biol Chem (2002) 1.06
RNase H activity is required for high-frequency repeat deletion during Moloney murine leukemia virus replication. J Virol (2002) 1.05
Identification of a preferred region for recombination and mutation in HIV-1 gag. Virology (2004) 1.02
Steps of the acceptor invasion mechanism for HIV-1 minus strand strong stop transfer. J Biol Chem (2003) 1.02
Genetic reassortment and patch repair by recombination in retroviruses. J Biomed Sci (2000) 1.00
Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication. J Virol (2001) 1.00
Structure-based moloney murine leukemia virus reverse transcriptase mutants with altered intracellular direct-repeat deletion frequencies. J Virol (2000) 0.99
Utilization of nonhomologous minus-strand DNA transfer to generate recombinant retroviruses. J Virol (1997) 0.99
Hairpin-induced tRNA-mediated (HITME) recombination in HIV-1. Nucleic Acids Res (2006) 0.97
HIV-1 genetic recombination: experimental approaches and observations. AIDS Rev (2003) 0.97
Sequence, distance, and accessibility are determinants of 5'-end-directed cleavages by retroviral RNases H. J Biol Chem (2005) 0.97
Genotypic and phenotypic analysis of a novel 15-base insertion occurring between codons 69 and 70 of HIV type 1 reverse transcriptase. AIDS Res Hum Retroviruses (2002) 0.95
Pausing during reverse transcription increases the rate of retroviral recombination. J Virol (2006) 0.94
Characterization of unintegrated retroviral DNA with long terminal repeat-associated cell-derived inserts. J Virol (1992) 0.93
RNase H activity of reverse transcriptases on substrates derived from the 5' end of retroviral genome. J Biol Chem (1993) 0.92
Co-localization of gammaretroviral RNAs at their transcription site favours co-packaging. J Gen Virol (2006) 0.91
An RNA secondary structure bias for non-homologous reverse transcriptase-mediated deletions in vivo. Nucleic Acids Res (2004) 0.87
Human immunodeficiency virus type 1 transductive recombination can occur frequently and in proportion to polyadenylation signal readthrough. J Virol (2004) 0.86
Transduction of cellular sequence by a human immunodeficiency virus type 1-derived vector. J Virol (2001) 0.86
How some retroviruses got their oncogenes. Trends Biochem Sci (1993) 0.85
Evidence for the acquisition of multi-drug resistance in an HIV-1 clinical isolate via human sequence transduction. Virology (2006) 0.81
Mismatch extension during strong stop strand transfer and minimal homology requirements for replicative template switching during Moloney murine leukemia virus replication. J Mol Biol (2003) 0.80
Characterization of a unique retroviral recombinant containing 7S L sequences. J Virol (1993) 0.77
Strand transfer to the 5' part of a tRNA as a mechanism for retrovirus patch-repair recombination in vivo. J Gen Virol (2004) 0.77
Complementarity between RNA dimerization elements favors formation of functional heterozygous murine leukemia viruses. Virology (2004) 0.76
Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization. J Virol (2002) 2.89
The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev (2009) 2.02
Structure of a conserved retroviral RNA packaging element by NMR spectroscopy and cryo-electron tomography. J Mol Biol (2010) 1.71
NMR detection of structures in the HIV-1 5'-leader RNA that regulate genome packaging. Science (2011) 1.66
Human immunodeficiency virus type 1 genetic recombination is more frequent than that of Moloney murine leukemia virus despite similar template switching rates. J Virol (2003) 1.52
Transcriptional regulation of steroidogenic genes: STARD1, CYP11A1 and HSD3B. Exp Biol Med (Maywood) (2009) 1.46
The C-X-C chemokine IP-10 stimulates HIV-1 replication. Virology (2003) 1.36
Nonrandom packaging of host RNAs in moloney murine leukemia virus. J Virol (2005) 1.30
Retroviral RNA dimerization and packaging: the what, how, when, where, and why. PLoS Pathog (2010) 1.21
Involvement of protein kinase C and cyclic adenosine 3',5'-monophosphate-dependent kinase in steroidogenic acute regulatory protein expression and steroid biosynthesis in Leydig cells. Biol Reprod (2005) 1.17
Effects of varying sequence similarity on the frequency of repeat deletion during reverse transcription of a human immunodeficiency virus type 1 vector. J Virol (2002) 1.16
Identification of a minimal region of the HIV-1 5'-leader required for RNA dimerization, NC binding, and packaging. J Mol Biol (2012) 1.14
Nonrandom dimerization of murine leukemia virus genomic RNAs. J Virol (2004) 1.11
An RNA structural switch regulates diploid genome packaging by Moloney murine leukemia virus. J Mol Biol (2009) 1.10
Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. J Virol (2012) 1.10
Molecular mechanisms of insulin-like growth factor-I mediated regulation of the steroidogenic acute regulatory protein in mouse leydig cells. Mol Endocrinol (2005) 1.07
RNase H activity is required for high-frequency repeat deletion during Moloney murine leukemia virus replication. J Virol (2002) 1.05
Packaging of host mY RNAs by murine leukemia virus may occur early in Y RNA biogenesis. J Virol (2009) 1.01
7SL RNA is retained in HIV-1 minimal virus-like particles as an S-domain fragment. J Virol (2010) 0.99
Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects. J Biol Chem (2002) 0.97
HIV-1 genetic recombination: experimental approaches and observations. AIDS Rev (2003) 0.97
Cyanobacteria (Nostoc commune) used as a dietary item in the Peruvian highlands produce the neurotoxic amino acid BMAA. J Ethnopharmacol (2008) 0.96
Two distinct Moloney murine leukemia virus RNAs produced from a single locus dimerize at random. Virology (2005) 0.95
Future vision for the quality assurance of oncology clinical trials. Front Oncol (2013) 0.93
Prostaglandin E(2) inhibits replication of HIV-1 in macrophages through activation of protein kinase A. Cell Immunol (2002) 0.92
Pseudodiploid genome organization AIDS full-length human immunodeficiency virus type 1 DNA synthesis. J Virol (2007) 0.89
Synergistic activation of steroidogenic acute regulatory protein expression and steroid biosynthesis by retinoids: involvement of cAMP/PKA signaling. Endocrinology (2013) 0.88
Human immunodeficiency virus type 1 transductive recombination can occur frequently and in proportion to polyadenylation signal readthrough. J Virol (2004) 0.86
cis-Acting determinants of 7SL RNA packaging by HIV-1. J Virol (2012) 0.85
Phenotypic variations in lipoid congenital adrenal hyperplasia. Pediatr Endocrinol Rev (2006) 0.83
Evidence for the acquisition of multi-drug resistance in an HIV-1 clinical isolate via human sequence transduction. Virology (2006) 0.81
Inhibition of thromboxane a synthase activity enhances steroidogenesis and steroidogenic acute regulatory gene expression in MA-10 mouse Leydig cells. Endocrinology (2007) 0.81
A novel extract SB-300 from the stem bark latex of Croton lechleri inhibits CFTR-mediated chloride secretion in human colonic epithelial cells. J Ethnopharmacol (2004) 0.80
Mismatch extension during strong stop strand transfer and minimal homology requirements for replicative template switching during Moloney murine leukemia virus replication. J Mol Biol (2003) 0.80
Characterization of a natural heterodimer between MLV genomic RNA and the SD' retroelement generated by alternative splicing. RNA (2007) 0.79
HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype. AIDS (2013) 0.78
Moloney murine leukemia virus genomic RNA packaged in the absence of a full complement of wild type nucleocapsid protein. Virology (2012) 0.76
STARD6 is expressed in steroidogenic cells of the ovary and can enhance de novo steroidogenesis. Exp Biol Med (Maywood) (2014) 0.76